Peer-influenced content. Sources you trust. No registration required. This is HCN.

Essential Medical Reading

Your Weekly Roundup of the Most-Read News and Clinical References from Your Peers

ReachMD

CME: Practicing Precision in ALK and ROS1 Rearrangement Positive Non-Small Cell Lung Cancer (NSCLC): Testing, Targets, and Treatments

Oncology, Medical May 25th 2022

Cancer Therapy Advisor

Sintilimab Provides ‘Robust’ Survival Benefit in Advanced Non-Small Cell Lung Cancer (NSCLC)

Oncology, Medical May 25th 2022

ASCO Educational Book

Overcoming KRAS-Mutant Lung Cancer

Oncology, Medical May 25th 2022

Cancer Therapy Advisor

Neoadjuvant Nivolumab Plus Chemo Deemed New Standard Care for Resectable Non-Small Cell Lung Cancer (NSCLC)

Oncology, Medical May 25th 2022

OBR Oncology

BMS Provides Update on CheckMate-901 Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) as First-Line Treatment for Patients with Unresectable or Metastatic Urothelial Carcinoma

Oncology, Medical May 25th 2022

Clinical Advances in Hematology & Oncology

CAR T-Cell Therapy for Relapsed/Refractory Non-Hodgkin’s Lymphoma (NHL): A Comprehensive Review

Oncology, Medical May 25th 2022